Not currently recruiting at UCSF
Assessing the Feasibility of BGC101 in the Treatment of PAD & CLI
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Michael Conte, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Michael Conte, MD
Professor, Surgery, School of Medicine. Authored (or co-authored) 271 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- BioGenCell Ltd.
- ID
- NCT02805023
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 50 study participants
- Last Updated